Cargando…
The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
OBJECTIVE: Two studies have reported that patients with the 4G/4G genotype of the plasminogen activator inhibitor-1 (PAI-1) genetic polymorphism had higher plasma PAI-1 concentrations and higher risk of death than those with the 4G/5G or 5G/5G genotypes; one study involved 175 children with meningoc...
Autores principales: | Lorente, Leonardo, Martín, María M., Borreguero-León, Juan M., Barrios, Ysamar, Solé-Violán, Jordi, Ferreres, José, Labarta, Lorenzo, Díaz, César, Jiménez, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466252/ https://www.ncbi.nlm.nih.gov/pubmed/26066833 http://dx.doi.org/10.1371/journal.pone.0129565 |
Ejemplares similares
-
Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009) -
Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients
por: Lorente, Leonardo, et al.
Publicado: (2016) -
Epidemiology and outcome of patients with severe sepsis in six Spanish ICUs
por: Lorente, L, et al.
Publicado: (2009) -
In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013) -
The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)